Back to News

Top 20 Pharmaceutical Company Selects ³Ô¹Ï±¬ÁÏ Vault CDMS for Enterprise-wide Deployment

PLEASANTON, CA ¡ª April 16, 2019 ¡ª ³Ô¹Ï±¬ÁÏ Systems (NYSE:VEEV) today announced that a top 20 pharmaceutical company has selected ³Ô¹Ï±¬ÁÏ Vault Clinical Data Management System (CDMS) as their global standard for EDC, coding, data cleaning, and reporting.

¡°This is a landmark announcement for the clinical data management market,¡± said Henry Levy, general manager, ³Ô¹Ï±¬ÁÏ Vault CDMS. ¡°³Ô¹Ï±¬ÁÏ Vault CDMS was selected because the company wanted a modern cloud solution on a world-class platform from a partner they could trust.¡±

Vault CDMS provides a suite of clinical data management applications that combines coding, EDC, data cleaning, and reporting all on a single cloud platform. Companies can now manage study build through execution in an integrated way. With a complete and concurrent view of their data, clinical development teams can make better decisions faster.

As part of Vault CDMS, ³Ô¹Ï±¬ÁÏ Vault EDC provides a fast and intuitive interface for capturing clinical trial data. Designed for flexibility, Vault EDC allows customers to run complex multi-arm adaptive trials and make mid-study amendments without downtime or migrations.

¡°Our goal is to become the market leader in the clinical data management market over time through innovation and product excellence,¡± added Levy. ¡°We are honored to partner with this important customer and look forward to delivering customer success for many years.¡±

Additional Information
For more on ³Ô¹Ï±¬ÁÏ Vault CDMS, visit: veeva.com/CDMS
Connect with ³Ô¹Ï±¬ÁÏ on LinkedIn:
Follow @veevasystems on Twitter:
Like ³Ô¹Ï±¬ÁÏ on Facebook:

About ³Ô¹Ï±¬ÁÏ Systems
³Ô¹Ï±¬ÁÏ Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 700 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. ³Ô¹Ï±¬ÁÏ is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com.

Forward-looking Statements
This release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ¡¯s products and services, the results from use of ³Ô¹Ï±¬ÁÏ¡¯s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ¡¯s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ¡¯s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ¡¯s financial results are included under the captions, ¡°Risk Factors¡± and ¡°Management¡¯s Discussion and Analysis of Financial Condition and Results of Operations,¡± in the company¡¯s filing on Form 10-K for the period ended January 31, 2019. This is available on the company¡¯s website at veeva.com under the Investors section and on the SEC¡¯s website at . Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.

###

Contact:
³Ô¹Ï±¬ÁÏ Systems
pr@veeva.com